Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cathepsin C | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | cathepsin C | 141 aa | 152 aa | 22.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0066 | 0.0099 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0171 | 0.6694 | 1 |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.0171 | 0.6694 | 1 |
Trypanosoma cruzi | cyclin 6, putative | 0.0107 | 0.3139 | 1 |
Echinococcus multilocularis | cyclin B3 1 | 0.0055 | 0.0273 | 0.0408 |
Plasmodium falciparum | cyclin | 0.0055 | 0.0273 | 0.0273 |
Trichomonas vaginalis | cyclins, putative | 0.0055 | 0.0273 | 0.0531 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.023 | 1 | 1 |
Echinococcus granulosus | cyclins | 0.0055 | 0.0273 | 0.0408 |
Echinococcus granulosus | cyclins | 0.0055 | 0.0273 | 0.0408 |
Schistosoma mansoni | cyclins | 0.0055 | 0.0273 | 0.0273 |
Leishmania major | CYC2-like cyclin, putative,cyclin 6, putative | 0.0107 | 0.3139 | 1 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.023 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0055 | 0.0273 | 0.0408 |
Echinococcus multilocularis | cyclins | 0.0055 | 0.0273 | 0.0408 |
Trichomonas vaginalis | cyclins, putative | 0.0107 | 0.3139 | 0.6103 |
Toxoplasma gondii | cathepsin CPC1 | 0.023 | 1 | 1 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.023 | 1 | 1 |
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.0087 | 0.2057 | 0.2057 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.023 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.3139 | 0.4689 |
Schistosoma mansoni | cyclin B | 0.0107 | 0.3139 | 0.3139 |
Echinococcus multilocularis | cyclins | 0.0055 | 0.0273 | 0.0408 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0.0273 | 0.0531 |
Echinococcus multilocularis | cyclin B | 0.0107 | 0.3139 | 0.4689 |
Echinococcus granulosus | cyclin B | 0.0107 | 0.3139 | 0.4689 |
Entamoeba histolytica | cyclin, putative | 0.0107 | 0.3139 | 1 |
Echinococcus multilocularis | cyclin b3 | 0.0055 | 0.0273 | 0.0408 |
Echinococcus multilocularis | cyclins | 0.0055 | 0.0273 | 0.0408 |
Trichomonas vaginalis | cyclin D, putative | 0.0055 | 0.0273 | 0.0531 |
Trichomonas vaginalis | cyclin B, putative | 0.0107 | 0.3139 | 0.6103 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.3139 | 0.4689 |
Giardia lamblia | Hypothetical protein | 0.0055 | 0.0273 | 0.0273 |
Trichomonas vaginalis | cyclins, putative | 0.0065 | 0.0808 | 0.157 |
Trichomonas vaginalis | cyclin A, putative | 0.0107 | 0.3139 | 0.6103 |
Giardia lamblia | Encystation-specific protease | 0.0087 | 0.2057 | 0.2057 |
Schistosoma mansoni | cyclin B3 | 0.0171 | 0.6694 | 0.6694 |
Echinococcus granulosus | cyclins | 0.0055 | 0.0273 | 0.0408 |
Trypanosoma brucei | mitotic cyclin 6 | 0.0107 | 0.3139 | 1 |
Trichomonas vaginalis | cyclin B, putative | 0.0107 | 0.3139 | 0.6103 |
Trypanosoma cruzi | CYC2-like cyclin, putative | 0.0107 | 0.3139 | 1 |
Onchocerca volvulus | 0.0107 | 0.3139 | 1 | |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.023 | 1 | 1 |
Trichomonas vaginalis | cyclin B, putative | 0.0107 | 0.3139 | 0.6103 |
Trichomonas vaginalis | cyclin D, putative | 0.0055 | 0.0273 | 0.0531 |
Trypanosoma cruzi | cyclin, putative | 0.0107 | 0.3139 | 1 |
Echinococcus multilocularis | cyclins | 0.0055 | 0.0273 | 0.0408 |
Trichomonas vaginalis | cyclin B, putative | 0.0055 | 0.0273 | 0.0531 |
Echinococcus granulosus | cyclin b3 | 0.0055 | 0.0273 | 0.0408 |
Trichomonas vaginalis | cyclins, putative | 0.0107 | 0.3139 | 0.6103 |
Plasmodium falciparum | dipeptidyl aminopeptidase 3 | 0.0087 | 0.2057 | 0.2057 |
Entamoeba histolytica | cyclin family protein | 0.0055 | 0.0273 | 0.087 |
Trichomonas vaginalis | cyclins, putative | 0.0107 | 0.3139 | 0.6103 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.023 | 1 | 1 |
Trypanosoma cruzi | cyclin, putative | 0.0107 | 0.3139 | 1 |
Echinococcus granulosus | cyclin B3 1 | 0.0055 | 0.0273 | 0.0408 |
Echinococcus granulosus | cyclins | 0.0055 | 0.0273 | 0.0408 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0143 | 0.5143 | 1 |
Echinococcus multilocularis | cyclins | 0.0055 | 0.0273 | 0.0408 |
Giardia lamblia | Cyclin A | 0.0055 | 0.0273 | 0.0273 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.0171 | 0.6694 | 1 |
Giardia lamblia | G2/mitotic-specific cyclin B | 0.0107 | 0.3139 | 0.3139 |
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.0087 | 0.2057 | 0.2057 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0107 | 0.3139 | 0.4689 |
Echinococcus granulosus | cyclins | 0.0055 | 0.0273 | 0.0408 |
Entamoeba histolytica | cyclin, putative | 0.0055 | 0.0273 | 0.087 |
Echinococcus multilocularis | G2:mitotic specific cyclin B3 | 0.0171 | 0.6694 | 1 |
Leishmania major | cyclin | 0.0107 | 0.3139 | 1 |
Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | 0.0087 | 0.2057 | 0.2057 |
Echinococcus multilocularis | cyclins | 0.0055 | 0.0273 | 0.0408 |
Toxoplasma gondii | cathepsin CPC2 | 0.0087 | 0.2057 | 0.2057 |
Trichomonas vaginalis | cyclin B3, putative | 0.0055 | 0.0273 | 0.0531 |
Trichomonas vaginalis | cyclin B, putative | 0.0107 | 0.3139 | 0.6103 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0107 | 0.3139 | 0.4689 |
Entamoeba histolytica | cyclin family protein | 0.0055 | 0.0273 | 0.087 |
Trichomonas vaginalis | cyclins, putative | 0.0107 | 0.3139 | 0.6103 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.